GLP-1 drugs may lower risk of 10 obesity-related cancers, study shows

Team Metabolic Health

Lindsey Wang, researcher at the School of Medicine, discussed her new research showing that weight-loss drugs, including Ozempic, are linked to a lower risk of cancer. “Most notably, we observed a significant risk reduction across multiple gastrointestinal cancers,” Wang said. “This broad spectrum of effects is significant given the often poor prognosis associated with these cancers.”

Credit: The Daily